IM Cannabis Secures Another Highly Dilutive Convertible Note and Warrants for $225K
IMCC sits 28% above its 52-week low of $0.12 on light trading volume (0.2× avg).
Summary
IM Cannabis Corp. closed a US$225,000 convertible note and warrant financing, receiving US$202,500 in net proceeds under highly dilutive terms, providing essential short-term capital amidst ongoing financial distress.
Key Events · Financing and Capital Events · IMCC
-
New Convertible Note and Warrants
IM Cannabis Corp. closed a US$225,000 convertible note financing, receiving US$202,500 in net proceeds, coupled with warrants to purchase 1,483,386 common shares at C$0.22.
-
Highly Dilutive Terms
The convertible note features a variable conversion price, set at the lower of US$0.152 or 90% of the 20-day VWAP, with a floor of US$0.0303, indicating significant potential dilution for existing shareholders.
-
Context of Financial Distress
This financing follows a series of similar dilutive capital raises and a recent 'going concern' warning, highlighting the company's urgent need for capital to sustain operations.
-
Support for Operations Amidst Strategic Review
The proceeds are designated for general corporate purposes, providing short-term liquidity as the company pursues a non-binding letter of intent to sell its European operations.
Analysis · IMCC · Life Sciences
IM Cannabis Corp. has secured a US$225,000 convertible note and warrants, providing US$202,500 in net proceeds. This financing is critical for the company's short-term liquidity, especially given its recent 'going concern' warning and Nasdaq bid price non-compliance. However, the terms are highly dilutive, featuring a variable conversion price that can drop to a US$0.0303 floor and significant warrant coverage. This continues a pattern of costly capital raises, reflecting the company's urgent need for funds amidst ongoing financial distress and while it pursues a potential divestiture of its European operations.
How filings like this one have moved
In the 30 days to Oct 22, 2026, 46.1% of the 284 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.53%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, IMCC was trading at $0.15 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $965.2K. The 52-week trading range was $0.12 to $3.75. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.